Loading...
Docoh
Log in Free sign up

Asensus Surgical (ASXC)

Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking the Clinical Intelligence to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare.

Company profile

Ticker
ASXC
Exchange
NYSE
Website
asensus.com
CEO
Anthony Fernando
Employees
Incorporated
Delaware
Location
North Carolina
Fiscal year end
Dec 31
Sector
Manufacturing > Surgical and Medical Instrument Manufacturing
Industry (SIC)
Surgical & Medical Instruments & Apparatus
3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Haemonetics • Hill-Rom • Nuvasive ...
Former names
CELLULAR TECHNICAL SERVICES CO INC, SafeStitch Medical, Inc., TRANSENTERIX INC., TRANSENTERIX, INC.
SEC CIK
0000876378
Corporate docs
Subsidiaries
Asensus Surgical US, Inc. • Asensus International, Inc. • Asensus Surgical Italia, S.r.l. • Asensus Surgical Europe • Asensus Surgical Netherlands B.V. • Asensus Surgical Israel Ltd • Asensus Surgical Canada, Inc. • Asensus Surgical Japan K.K. • Asensus Taiwan Ltd. ...
IRS number
112962080

ASXC stock data

News

From Benzinga Pro
HC Wainwright & Co. Maintains Buy on Asensus Surgical, Lowers Price Target to $3
10 Aug 22
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Asensus Surgical (AMEX:ASXC) with a Buy and lowers the price target from $4 to $3.
Recap: Asensus Surgical Q2 Earnings
8 Aug 22
Asensus Surgical (AMEX:ASXC) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Asensus Surgical Q2 EPS $(0.07) Beats $(0.08) Estimate, Sales $994.00K Miss $1.25M Estimate
8 Aug 22
Asensus Surgical (AMEX:ASXC) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 40 percent decrease over losses of $(0.05) per share from the
Earnings Scheduled For August 8, 2022
8 Aug 22
Asensus Surgical Earlier Announced Sale Of Senhance Robotic System
4 Aug 22

Press releases

From Benzinga Pro
Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2022
8 Aug 22
RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE:ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of
Asensus Surgical Announces Sale of Senhance Robotic System
4 Aug 22
RESEARCH TRIANGLE PARK, N.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE:ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of
Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 8, 2022
26 Jul 22
RESEARCH TRIANGLE PARK, N.C., July 26, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE:ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of
Asensus Surgical Announces Installation of Senhance Surgical System in the Department of Gynecology at University Hospital Tübingen
7 Jul 22
The Ascension of Asensus in Performance-Guided Surgery
28 Jun 22

Analyst ratings and price targets

Last 3 months
HC Wainwright & Co.
Maintains
Buy
$3.00
10 Aug 22

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

8 Aug 22
16 Aug 22
31 Dec 22

Financial summary

Financial statements Chart ASXC financial data
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 12.13M 12.13M 12.13M 12.13M 12.13M 12.13M
Cash burn (monthly) 4.62M 12.17M 6.52M 5.98M 4.76M 4.37M
Cash used (since last report) 7.26M 19.1M 10.24M 9.38M 7.48M 6.85M
Cash remaining 4.88M -6.96M 1.9M 2.75M 4.66M 5.28M
Runway (months of cash) 1.1 -0.6 0.3 0.5 1.0 1.2

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Recent insider trades

ASXC insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
1 Jul 22 Shameze Rampertab Common Stock Payment of exercise Dispose F No No 0.38 7,015 2.67K 93,658
1 Jul 22 Shameze Rampertab Common Stock Option exercise Acquire M No No 0 16,667 0 100,673
1 Jul 22 Shameze Rampertab RSU Common Stock Option exercise Dispose M No No 0 6,667 0 6,666
1 Jul 22 Shameze Rampertab RSU Common Stock Option exercise Dispose M No No 0 10,000 0 10,000
17 Jun 22 Biffi Andrea Common Stock Other Acquire J Yes No 0 1,482,008 0 1,482,008
14 Jun 22 David Bruce Milne Stock Option Common Stock Grant Acquire A No No 0.38 55,340 21.03K 55,340
14 Jun 22 Elizabeth Kwo Stock Option Common Stock Grant Acquire A No No 0.38 55,340 21.03K 55,340
14 Jun 22 Pfenniger Richard C JR Common Stock Grant Acquire A No No 0 45,000 0 144,417
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

ASXC institutional ownership history Ownership history
13F holders Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 1 EXIT
Increased positions 0 0
Reduced positions 0 0
13F shares Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio – – –
Largest owners Shares Value Change
Largest transactions Shares Bought/sold Change
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

?
Competition
Medtronic • Titan Medical • Intuitive Surgical • Medtronic • Vicarious Surgical

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: Andrea, assignee, Biffi, book, chose, cloud, effort, geopolitical, headcount, Med, member, overstated, Person, raw, recover, revised, revision, timeline, Ukraine, understated, war
Removed: acquired, approved, April, closing, long, month, proxy, withholding
From filing 10-Q 2022 Q2
Financial reports
View all
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
10-K
2021 FY
Annual report
28 Feb 22
10-Q
2021 Q3
Quarterly report
3 Nov 21
10-Q
2021 Q2
Quarterly report
5 Aug 21
10-Q
2021 Q1
Quarterly report
11 May 21
10-K
2020 FY
Annual report
11 Mar 21
10-Q
2020 Q3
Quarterly report
5 Nov 20
10-Q
2020 Q2
Quarterly report
5 Aug 20
10-Q
2020 Q1
Quarterly report
15 May 20
Current reports
View all
8-K
Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2022
11 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 22
8-K
Other Events
10 May 22
8-K
Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2022
5 May 22
8-K
Entry into a Material Definitive Agreement
18 Mar 22
8-K
Departure of Directors or Certain Officers
15 Mar 22
8-K
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2021
2 Mar 22
8-K
Departure of Directors or Certain Officers
7 Feb 22
8-K
Regulation FD Disclosure
13 Jan 22
8-K
Asensus Surgical Provides Preliminary 2021 Year-End Corporate Update
10 Jan 22
Registration and prospectus
View all
424B5
Prospectus supplement for primary offering
10 May 22
S-3
Shelf registration
18 Mar 22
S-8
Registration of securities for employees
26 Jul 21
424B5
Prospectus supplement for primary offering
19 May 21
S-3ASR
Automatic shelf registration
19 May 21
424B5
Prospectus supplement for primary offering
28 Jan 21
FWP
Free writing prospectus
27 Jan 21
FWP
Free writing prospectus
27 Jan 21
FWP
Free writing prospectus
26 Jan 21
424B5
Prospectus supplement for primary offering
26 Jan 21
Proxies
View all
DEFA14A
Additional proxy soliciting materials
25 Apr 22
DEF 14A
Definitive proxy
25 Apr 22
DEFA14A
Additional proxy soliciting materials
15 Jul 21
DEFA14A
Additional proxy soliciting materials
29 Jun 21
DEFA14A
Additional proxy soliciting materials
22 Jun 21
DEFA14A
Additional proxy soliciting materials
3 Jun 21
DEFA14A
Additional proxy soliciting materials
28 Apr 21
DEFA14A
Additional proxy soliciting materials
22 Apr 21
DEF 14A
Definitive proxy
22 Apr 21
DEFA14A
Additional proxy soliciting materials
27 Apr 20
Other
View all
EFFECT
Notice of effectiveness
29 Apr 22
CORRESP
Correspondence with SEC
25 Apr 22
UPLOAD
Letter from SEC
22 Mar 22
EFFECT
Notice of effectiveness
28 May 20
CORRESP
Correspondence with SEC
21 May 20
UPLOAD
Letter from SEC
21 May 20
EFFECT
Notice of effectiveness
14 Feb 20
CORRESP
Correspondence with SEC
11 Feb 20
UPLOAD
Letter from SEC
11 Feb 20
EFFECT
Notice of effectiveness
11 Feb 20
Ownership
View all
SC 13G
ASENSUS SURGICAL / BlackRock ownership change
8 Jul 22
4
ASENSUS SURGICAL / Rampertab Shameze ownership change
5 Jul 22
4
ASENSUS SURGICAL / Andrea Biffi ownership change
22 Jun 22
4
ASENSUS SURGICAL / Kevin J Hobert ownership change
15 Jun 22
4
ASENSUS SURGICAL / Andrea Biffi ownership change
15 Jun 22
4
ASENSUS SURGICAL / RICHARD C PFENNIGER JR ownership change
15 Jun 22
4
ASENSUS SURGICAL / William N Starling JR ownership change
15 Jun 22
4
ASENSUS SURGICAL / David Bruce Milne ownership change
15 Jun 22
4
ASENSUS SURGICAL / Elizabeth Kwo ownership change
15 Jun 22
4
ASENSUS SURGICAL / Elizabeth Kwo ownership change
16 Mar 22

Patents

View all
Utility
Roboticized Surgery System with Improved Control
23 Jun 22
A robotized surgery system comprises at least one robot arm which acts under the control of a control console intended for the surgeon.
Utility
Instrument end effector identification
3 May 22
A mechanical assembly is used to communicate to a robotic system information about a type of instrument mounted to a robotic manipulator arm.
Utility
Electromechanical Surgical System Including Linearly Driven Instrument Roll
21 Apr 22
A surgical system includes a drive unit on a support.
Utility
Dynamic Control of Surgical Instruments In a Surgical Robotic System
21 Apr 22
A robotic surgical system configured to control movement of a first instrument and a second instrument, each of which is on a robotic manipulator.
Utility
Dynamic Scaling for a Robotic Surgical System
21 Apr 22
A robotic surgical system in which the system applies a scaling factor between user input from a user input device and corresponding movements of the robotic manipulator.

Transcripts

View all
2022 Q2
Earnings call transcript
9 Aug 22
2022 Q1
Earnings call transcript
5 May 22
2021 Q4
Earnings call transcript
1 Mar 22
2021 Q3
Earnings call transcript
3 Nov 21
2021 Q2
Earnings call transcript
6 Aug 21
2021 Q1
Earnings call transcript
11 May 21
2020 Q4
Earnings call transcript
12 Mar 21
2020 Q3
Earnings call transcript
5 Nov 20
2020 Q2
Earnings call transcript
5 Aug 20
2020 Q1
Earnings call transcript
14 May 20

Reddit threads

View all